STOCK TITAN

Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
earnings date

Labcorp (NYSE: LH) will release fourth-quarter 2025 financial results before the market opens on Tuesday, February 17, 2026. A conference call and live webcast will begin at 9:00 a.m. ET that day to discuss results, with the earnings release and financial materials posted on the Labcorp Investor Relations website.

Participants may register to receive dial-in numbers and a unique PIN; the webcast and dial-in are listen-only. It is recommended to join 10 minutes before the start. A replay of the webcast will be available about two hours after the live event and remain accessible until February 4, 2027 on the Investor Relations site.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – DRUG

-2.12%
1 alert
-2.12% News Effect

On the day this news was published, DRUG declined 2.12%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

BURLINGTON, N.C., Jan. 15, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2025 before the market opens on Tuesday, February 17, 2026. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

The call will be webcast live on the Labcorp Investor Relations website. Participants may also register for the call by clicking on this link, to receive the dial-in numbers and unique PIN to access the call. The webcast and dial-in are listen-only. It is recommended that participants join 10 minutes prior to the start, although participants may register and join at any time during the call.

A replay of the webcast will be available approximately two hours after the conclusion of the live event and will be available until February 4, 2027. To access the webcast recording, visit the Labcorp Investor Relations website.

About Labcorp

Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved in 2024 by the FDA, and perform more than 700 million tests annually for patients around the world. Learn more about us at www.labcorp.com.

FAQ

When will Labcorp (LH) report fourth-quarter 2025 earnings?

Labcorp will release Q4 2025 results before the market opens on February 17, 2026.

What time is the Labcorp (LH) earnings webcast on February 17, 2026?

The company will host a conference call and live webcast beginning at 9:00 a.m. ET.

How can investors access the Labcorp (LH) Q4 2025 earnings call and materials?

Earnings materials and the live webcast will be posted on the Labcorp Investor Relations website; participants can register to receive dial-in details and a PIN.

Will there be a replay of the Labcorp (LH) February 17, 2026 webcast?

Yes. A replay will be available about two hours after the live event and will remain accessible until February 4, 2027 on the Investor Relations site.

Is the Labcorp (LH) earnings call interactive or listen-only?

The webcast and dial-in are listen-only.
Bright Minds Biosciences Inc

NASDAQ:DRUG

DRUG Rankings

DRUG Latest News

DRUG Latest SEC Filings

DRUG Stock Data

875.89M
8.21M
Biotechnology
Healthcare
Link
United States
New York